Annual report
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Income | |||
| RevenueRM | 10,184,330 | 8,152,797 | PDF p. 110 |
| Cost of salesRM | (6,940,967) | (5,504,299) | PDF p. 110 |
| Gross profitRM | 3,243,363 | 2,648,498 | PDF p. 110 |
| Other incomeRM | 133,591 | 279,921 | PDF p. 110 |
| Other gains/(losses) | |||
| - Reversal/(Loss) allowance on financial assetsRM | 267,682 | (1,407,089) | PDF p. 110 |
| - Fair value gain on biological assetsRM | 1,854,590 | 5,770,245 | PDF p. 110 |
| - OthersRM | (151) | (728) | PDF p. 110 |
| Expenses | |||
| - DistributionRM | (1,837,311) | (1,236,540) | PDF p. 110 |
| - AdministrativeRM | (7,348,293) | (8,414,307) | PDF p. 110 |
| - FinanceRM | (637,177) | (94,701) | PDF p. 110 |
| Income | |||
| Loss before income taxRM | (4,323,706) | (2,454,701) | PDF p. 110 |
| Income tax credit/(expense)RM | 850,331 | (229,669) | PDF p. 110 |
| Total comprehensive loss, representing net loss for the financial yearRM | (3,473,375) | (2,684,370) | PDF p. 110 |
| Attributable to | |||
| Equity holders of the CompanyRM | (2,610,451) | (2,094,664) | PDF p. 110 |
| Non-controlling interestsRM | (862,924) | (589,706) | PDF p. 110 |
| SubtotalRM | (3,473,375) | (2,684,370) | PDF p. 110 |
| Loss per share for loss attributable to equity holders of the Company | |||
| Basic and dilutedSen per share | (2.20) | (1.77) | PDF p. 110 |
Original report: PDF p. 110 ↗
The accompanying notes form an integral part of these financial statements.
For the financial year ended 31 July 2025. Loss per share (Sen per share).
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Current assets | |||
| Cash and bank balancesRM | 2,436,197 | 8,909,814 | PDF p. 111 |
| Trade and other receivablesRM | 4,778,614 | 6,570,340 | PDF p. 111 |
| Income tax recoverableRM | 404,408 | 1,701,986 | PDF p. 111 |
| InventoriesRM | 316,414 | 1,479,638 | PDF p. 111 |
| SubtotalRM | 7,935,633 | 18,661,778 | PDF p. 111 |
| Non-current assets | |||
| Other receivablesRM | 1,597,623 | 1,490,744 | PDF p. 111 |
| Property, plant and equipmentRM | 4,736,582 | 4,932,940 | PDF p. 111 |
| Right-of-use assetsRM | 830,986 | 999,793 | PDF p. 111 |
| Biological assetsRM | 52,458,000 | 42,200,000 | PDF p. 111 |
| Intangible assetRM | 450,000 | 455,000 | PDF p. 111 |
| SubtotalRM | 60,073,191 | 50,078,477 | PDF p. 111 |
| Assets | |||
| Total assetsRM | 68,008,824 | 68,740,255 | PDF p. 111 |
| Current liabilities | |||
| Trade and other payablesRM | 2,658,440 | 3,145,896 | PDF p. 111 |
| BorrowingsRM | 4,586,673 | 1,286,879 | PDF p. 111 |
| SubtotalRM | 7,245,113 | 4,432,775 | PDF p. 111 |
| Non-current liabilities | |||
| BorrowingsRM | 17,257,547 | 16,477,610 | PDF p. 111 |
| Deferred income tax liabilitiesRM | 2,613,844 | 3,464,175 | PDF p. 111 |
| SubtotalRM | 19,871,391 | 19,941,785 | PDF p. 111 |
| Liabilities | |||
| Total liabilitiesRM | 27,116,504 | 24,374,560 | PDF p. 111 |
| NET ASSETSRM | 40,892,320 | 44,365,695 | PDF p. 111 |
| Equity | |||
| Share capitalRM | 15,207,073 | 15,207,073 | PDF p. 111 |
| Retained earningsRM | 16,508,028 | 16,523,535 | PDF p. 111 |
| Strategic reserveRM | – | 2,594,944 | PDF p. 111 |
| SubtotalRM | 31,715,101 | 34,325,552 | PDF p. 111 |
| Non-controlling interestsRM | 9,177,219 | 10,040,143 | PDF p. 111 |
| TOTAL EQUITYRM | 40,892,320 | 44,365,695 | PDF p. 111 |
Original report: PDF p. 111 ↗
As at 31 July 2025. The accompanying notes form an integral part of these financial statements.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Company | 2024Company | Source |
|---|---|---|---|
| Current assets | |||
| Cash and bank balancesRM | 993,501 | 4,133,674 | PDF p. 112 |
| Trade and other receivablesRM | 1,577,893 | 37,027 | PDF p. 112 |
| SubtotalRM | 2,571,394 | 4,170,701 | PDF p. 112 |
| Non-current assets | |||
| Other receivableRM | 8,068,676 | 7,627,503 | PDF p. 112 |
| Investment in a subsidiary corporationRM | 2,350,000 | 2,350,000 | PDF p. 112 |
| SubtotalRM | 10,418,676 | 9,977,503 | PDF p. 112 |
| Assets | |||
| Total assetsRM | 12,990,070 | 14,148,204 | PDF p. 112 |
| Current liabilities | |||
| Trade and other payablesRM | 289,635 | 865,190 | PDF p. 112 |
| Liabilities | |||
| NET ASSETSRM | 12,700,435 | 13,283,014 | PDF p. 112 |
| Equity | |||
| Share capitalRM | 15,207,073 | 15,207,073 | PDF p. 112 |
| Accumulated lossesRM | (2,506,638) | (1,924,059) | PDF p. 112 |
| TOTAL EQUITYRM | 12,700,435 | 13,283,014 | PDF p. 112 |
Original report: PDF p. 112 ↗
As at 31 July 2025. The accompanying notes form an integral part of these financial statements.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group, FY ended 31 July 2025 | 2024Group, FY ended 31 July 2024 | Source |
|---|---|---|---|
| Income | |||
| RevenueRM | 10,184,330 | 8,152,797 | PDF p. 110 |
| Cost of salesRM | (6,940,967) | (5,504,299) | PDF p. 110 |
| Gross profitRM | 3,243,363 | 2,648,498 | PDF p. 110 |
| Other incomeRM | 133,591 | 279,921 | PDF p. 110 |
| Other gains/(losses) | |||
| - Reversal/(Loss) allowance on financial assetsRM | 267,682 | (1,407,089) | PDF p. 110 |
| - Fair value gain on biological assetsRM | 1,854,590 | 5,770,245 | PDF p. 110 |
| - OthersRM | (151) | (728) | PDF p. 110 |
| Expenses | |||
| - DistributionRM | (1,837,311) | (1,236,540) | PDF p. 110 |
| - AdministrativeRM | (7,348,293) | (8,414,307) | PDF p. 110 |
| - FinanceRM | (637,177) | (94,701) | PDF p. 110 |
| Income | |||
| Loss before income taxRM | (4,323,706) | (2,454,701) | PDF p. 110 |
| Income tax credit/(expense)RM | 850,331 | (229,669) | PDF p. 110 |
| Total comprehensive loss, representing net loss for the financial yearRM | (3,473,375) | (2,684,370) | PDF p. 110 |
| Attributable to | |||
| Equity holders of the CompanyRM | (2,610,451) | (2,094,664) | PDF p. 110 |
| Non-controlling interestsRM | (862,924) | (589,706) | PDF p. 110 |
| Loss per share (Sen per share) | |||
| Basic and dilutedSen per share | (2.20) | (1.77) | PDF p. 110 |
Original report: PDF p. 110 ↗
Currency RM (ringgit) as printed. Statement for the financial year ended 31 July 2025. No separate Company comprehensive income statement printed.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group, Share capital, RM | 2025Group, Retained earnings, RM | 2025Group, Strategic reserve, RM | 2025Group, Total attributable to equity holders, RM | 2025Group, Non-controlling interests, RM | 2025Group, Total equity, RM | Source |
|---|---|---|---|---|---|---|---|
| 2025 | |||||||
| Beginning of financial yearRM | 15,207,073 | 16,523,535 | 2,594,944 | 34,325,552 | 10,040,143 | 44,365,695 | PDF p. 113 |
| Total comprehensive loss for the financial yearRM | – | (2,610,451) | – | (2,610,451) | (862,924) | (3,473,375) | PDF p. 113 |
| Transfer between retained earnings and strategic reserveRM | – | 2,594,944 | (2,594,944) | – | – | – | PDF p. 113 |
| End of financial yearRM | 15,207,073 | 16,508,028 | – | 31,715,101 | 9,177,219 | 40,892,320 | PDF p. 113 |
| 2024 | |||||||
| Beginning of financial yearRM | 15,207,073 | 10,757,371 | 10,455,772 | 36,420,216 | 10,629,849 | 47,050,065 | PDF p. 113 |
| Total comprehensive loss for the financial yearRM | – | (2,094,664) | – | (2,094,664) | (589,706) | (2,684,370) | PDF p. 113 |
| Transfer between retained earnings and strategic reserveRM | – | 7,860,828 | (7,860,828) | – | – | – | PDF p. 113 |
| End of financial yearRM | 15,207,073 | 16,523,535 | 2,594,944 | 34,325,552 | 10,040,143 | 44,365,695 | PDF p. 113 |
Original report: PDF p. 113 ↗
Rows listed per movement; the 2025 and 2024 blocks are separate. Values order: share capital, retained earnings, strategic reserve, total attributable, NCI, total equity. For the 2024 block the column year is 2024 (see section). No separate Company statement of changes in equity is printed; Company equity components are in the Company statement of financial position.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group, FY ended 31 July 2025 | 2024Group, FY ended 31 July 2024 | Source |
|---|---|---|---|
| Operating activities | |||
| Net lossRM | (3,473,375) | (2,684,370) | PDF p. 114 |
| - Interest incomeRM | (120,700) | (248,483) | PDF p. 114 |
| - Fair value gain on biological assetsRM | (1,854,590) | (5,770,245) | PDF p. 114 |
| - (Reversal)/Loss allowance on trade receivablesRM | (267,682) | 1,407,089 | PDF p. 114 |
| - Deposit written offRM | – | 40,000 | PDF p. 114 |
| - Depreciation of property, plant and equipmentRM | 557,168 | 529,082 | PDF p. 114 |
| - Amortisation of intangible assetsRM | 5,000 | 5,000 | PDF p. 114 |
| - Depreciation of right-of-use assetsRM | 107,145 | 126,081 | PDF p. 114 |
| - Interest expenseRM | 637,177 | 94,701 | PDF p. 114 |
| - Income tax (credit)/expenseRM | (850,331) | 229,669 | PDF p. 114 |
| - Property, plant and equipment written offRM | – | 914 | PDF p. 114 |
| - Gain on lease terminationRM | – | (17,583) | PDF p. 114 |
| Subtotal before working capital (unlabelled)RM | (5,260,188) | (6,288,145) | PDF p. 114 |
| Changes in working capital | |||
| - InventoriesRM | 1,163,224 | (912,877) | PDF p. 114 |
| - Trade and other receivablesRM | 1,907,935 | (1,118,226) | PDF p. 114 |
| - Trade and other payablesRM | (487,456) | 1,404,934 | PDF p. 114 |
| Operating activities | |||
| Cash used in operationsRM | (2,676,485) | (6,914,314) | PDF p. 114 |
| Income tax refunded, netRM | 1,297,578 | – | PDF p. 114 |
| Net cash used in operating activitiesRM | (1,378,907) | (6,914,314) | PDF p. 114 |
| Investing activities | |||
| Additions to property, plant and equipmentRM | (607,670) | (1,575,719) | PDF p. 114 |
| Additions to biological assetsRM | (8,094,888) | (10,541,691) | PDF p. 114 |
| Interest income receivedRM | 165,294 | 288,512 | PDF p. 114 |
| Net cash used in investing activitiesRM | (8,537,264) | (11,828,898) | PDF p. 114 |
| Financing activities | |||
| Principal payment of lease liabilitiesRM | (152,295) | (210,125) | PDF p. 114 |
| Proceeds from borrowingsRM | 3,684,083 | 8,474,943 | PDF p. 114 |
| Interest paidRM | (81,234) | (94,701) | PDF p. 114 |
| Principal repayment of borrowingsRM | (8,000) | (16,000) | PDF p. 114 |
| Net cash provided by financing activitiesRM | 3,442,554 | 8,154,117 | PDF p. 114 |
| Net change | |||
| Net decrease in cash and cash equivalentRM | (6,473,617) | (10,589,095) | PDF p. 114 |
| Cash and cash equivalent | |||
| Beginning of financial yearRM | 7,909,814 | 18,498,909 | PDF p. 114 |
| End of financial yearRM | 1,436,197 | 7,909,814 | PDF p. 114 |
Original report: PDF p. 114 ↗
Currency RM. Printed spelling 'Cash and cash equivalent'. Reconciliation of liabilities from financing activities is on page 115 (not tabulated). No Company cash flow statement printed.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group, at 31 July 2025 | 2024Group, at 31 July 2024 | Source |
|---|---|---|---|
| Carrying value of non-controlling interests | |||
| Jawala Plantation Industries Sdn. Bhd.RM | 9,177,219 | 10,040,143 | PDF p. 135 |
Original report: PDF p. 135 ↗
NCI proportion of ordinary shares held: 30% in 2025 and 2024 (Jawala Plantation Industries Sdn. Bhd.).
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group FY2025 | 2024Group FY2024 | 2023Group FY2023 | Source |
|---|---|---|---|---|
| Income statement | ||||
| RevenueRM'000 | 10,184 | 8,153 | 11,203 | PDF p. 16 |
| Gross profitRM'000 | 3,243 | 2,648 | 4,302 | PDF p. 16 |
| Gross profit margin (%)% | 32 | 32 | 38 | PDF p. 16 |
| Loss before income taxRM'000 | (4,324) | (2,455) | (969) | PDF p. 16 |
| Loss after income taxRM'000 | (3,473) | (2,684) | (897) | PDF p. 16 |
| Loss attributable to | ||||
| Equity holders of the CompanyRM'000 | (2,610) | (2,095) | (856) | PDF p. 16 |
| Non-controlling interestsRM'000 | (863) | (590) | (41) | PDF p. 16 |
| Loss per share | ||||
| Basic and diluted (sen)sen | (2.2) | (1.8) | (0.7) | PDF p. 16 |
Original report: PDF p. 16 ↗
No dividend per share is shown in the highlights.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group, 31 July 2025 | 2024Group, 31 July 2024 | 2023Group, 31 July 2023 | Source |
|---|---|---|---|---|
| Balance sheet | ||||
| Current assetsRM'000 | 7,936 | 18,662 | 28,754 | PDF p. 16 |
| Non-current assetsRM'000 | 60,073 | 50,078 | 32,459 | PDF p. 16 |
| Current liabilitiesRM'000 | 7,245 | 4,433 | 1,977 | PDF p. 16 |
| Non-current liabilitiesRM'000 | 19,871 | 19,942 | 12,186 | PDF p. 16 |
| Total EquityRM'000 | 40,892 | 44,366 | 47,050 | PDF p. 16 |
Original report: PDF p. 16 ↗
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group FY2025 | 2024Group FY2024 | 2023Group FY2023 | Source |
|---|---|---|---|---|
| Cash flows | ||||
| Cash flows used in operating activitiesRM'000 | (1,379) | (6,914) | (5,588) | PDF p. 16 |
| Cash flows used in investing activitiesRM'000 | (8,537) | (11,829) | (7,791) | PDF p. 16 |
| Cash flows provided by financing activitiesRM'000 | 3,443 | 8,154 | 3,857 | PDF p. 16 |
| Cash and cash equivalents at the end of the yearRM'000 | 1,436 | 7,910 | 18,499 | PDF p. 16 |
Original report: PDF p. 16 ↗
The investing-activities row label and values are split across lines in the source; the quote is the values line.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group FY2025 | 2024Group FY2024 | Source |
|---|---|---|---|
| Numerator | |||
| Net loss attributable to equity holder of the Company (RM)RM | (2,610,451) | (2,094,664) | PDF p. 132 |
| Denominator | |||
| Weighted average number of ordinary shares (‘000)'000 shares | 118,474 | 118,474 | PDF p. 132 |
| EPS | |||
| Basic and diluted earnings per share (Sen per share)(1)sen per share | (2.20) | (1.77) | PDF p. 132 |
Original report: PDF p. 132 ↗
(1) The basic and fully diluted earnings per share are the same as there were no dilutive ordinary shares in issue as at 31 July 2025 and 2024.
Debt
| Item / unit | 2025RM | 2024RM | Source |
|---|---|---|---|
| Current | |||
| Lease liabilitiesRM | 116,429 | 152,293 | PDF p. 141 |
| BorrowingsRM | 4,470,244 | 1,134,586 | PDF p. 141 |
| Current totalRM | 4,586,673 | 1,286,879 | PDF p. 141 |
| Non-current | |||
| Lease liabilitiesRM | 951,582 | 1,068,013 | PDF p. 141 |
| BorrowingsRM | 16,305,965 | 15,409,597 | PDF p. 141 |
| Non-current totalRM | 17,257,547 | 16,477,610 | PDF p. 141 |
| Total | |||
| Total borrowingsRM | 21,844,220 | 17,764,489 | PDF p. 141 |
The borrowings of the Group are charged at a fixed interest rate of 3% per annum and not exposed to interest rate changes.
The borrowings are repayable over 5 years of instalment to commence at the earlier of the expiry of 180 months grace period from the first drawdown or the commencement of harvesting of the planted trees as disclosed in Note 19. Two borrowings were granted to the Group in year 2019 and 2022, with the disbursement received in financial year 2021, 2023, 2024 and 2025 respectively.
Security (p.142): secured over (i) corporate guarantee issued by immediate and ultimate holding corporation, Jawala Corporation Sdn. Bhd. and (ii) an area of approximately 6,762 hectares from a total of 11,043 hectares in the Sapulut Forest Reserve in Sabah, Malaysia. Fair value of non-current borrowings approximates carrying amount; discount rate 3% (2024: 3%), Level 3. Currency RM.
Payout
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Provision 11.6 - Dividend Policy | The Company does not have a fixed dividend policy. The Board had not declared or recommended dividend payment for FY2025 after taking into consideration, loss recorded by the Group. The Company recognises creation of long-term stakeholders’ value but given the current market outlook, the Company would conserve cash for the development of its industrial trees’ plantation. | Company, FY2025 | PDF p. 49 |
Extracted from Annual report and checked against the cited pages; see the original report for full context.
Auditor’s report
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Audit firm | PKF-CAP LLP | Group | PDF p. 109 |
| Engagement partner | Chew Wei Jim | Group | PDF p. 109 |
| Opinion | properly drawn up in accordance with Singapore Financial Reporting Standards (International) (“SFRS(I)”) so as to give a true and fair view | Group and Company | PDF p. 106 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| 4. Going concern | the financial statements of the Group have been prepared on a going concern basis as the Group will be able to meet its liabilities as when they fall due | Group | PDF p. 129 |
Extracted from Annual report and checked against the cited pages; see the original report for full context.
Group and parent company or bank figures are labelled separately. Parentheses indicate negative amounts; a dash and NA retain the report’s notation.
Comparative figures follow Annual report, including retrospective adjustments. Adjusted and reported earnings may have different definitions; refer to each statement’s notes.
These tables show the available extracted figures. The original annual report contains the full statements, notes and definitions.